Overview

Pharmacological Intervention in Insulin Resistance Targeting Autonomic Nerve Activity

Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The present study on pharmacological intervention in autonomic nervous dysregulation(parasympathetic dysfunction,) regarding insulin resistance, is a concept testing in humans tohelp identify potential new pharmacological target sites in the central nervous system.
Phase:
Early Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Atropine
Physostigmine